IMDRF terminologies for categorized Adverse Event Reporting (AER): terms, terminology structure and codes, 03/20 Anna Sandberg2021-09-29T12:28:17+00:00September 29th, 2021|
IMDRF Principles and Practices for Medical Device Cybersecurity, 03/20 Anna Sandberg2021-09-29T12:04:11+00:00September 29th, 2021|
FDA GFI, Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C of the FD&C Act, 03/20 Anna Sandberg2021-09-29T11:57:42+00:00September 29th, 2021|
FDA GFI, Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification, 06/21 Anna Sandberg2021-09-29T11:45:06+00:00September 29th, 2021|
IMDRF Post-Market Clinical Follow-Up Studies, 03/21 Anna Sandberg2021-09-28T14:30:08+00:00September 28th, 2021|
MHRA, A Guide to Defective Medicinal Products, 08/21 Anna Sandberg2021-09-28T14:19:30+00:00September 28th, 2021|